DEADLINESPONSOROPPORTUNITY TITLE/LINKADDITIONAL INFORMATION

June 9, 2020

NEW (06/03/20)

Society of Family Planning Research Fund (SFPRF)Contraceptive Services Delivery Capturing Innovations Responsive to COVID-19The sponsor is interested in proposals focusing on the question "What can be learned from the shifts in service delivery responsive to COVID-19 that can advance the delivery of evidence-based clinical care now and in the future?"

June 12, 2020

23andMeResearch Innovation Collaborations ProgramAs related to COVID-19, 23andMe will consider studies of outcomes, co-morbidities, health disparities and impacts of policies implemented to address the pandemic. Academic researchers are paired with 23andMe scientists and gain access to de-identified data from the 23andMe Research Cohort.
June 15, 2020Agency for Healthcare Research and Quality (AHRQ)Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) (RFA-HS-20-003)AHRQ wishes to fund research focused on 1) effects of quality, safety and value of health system response to COVID-19; 2) the role of primary care practices and professionals during the COVID-19 epidemic; 3) understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and 4) digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19.
June 30, 2020Amazon Web Services (AWS)AWS Diagnostic Development InitiativeThis Initiative supports AWS customers who are working to bring better, more accurate diagnostic solutions to market faster. Focused initially on COVID-19, researchers studying other infectious diseases will also be supported.
June 23, 2020American Thoracic Society (ATS)ATS/GSK Research Grants in COVID-19The sponsor is interested in funding research targeting pathobiology and clinical implications of COVID-19. Basic, clinical, translational and population health research efforts to answer questions about respiratory viral infections will be considered. Applicants must be at the Assistant Professor level and current ATS members.
Continuous submissionArgonne National Laboratory (US Department of Energy)Expedited, Rapid Access Call for COVID-19 Research SupportThe Advanced Photon Source at Argonne is offering remote access to beamlines for macromolecular crystallography and BioSAXS for research efforts related to SARS-CoV-2 or COVID-19.
No deadline indicatedArmy Applications Laboratory (AAL)COVID-19 InnovationsAAL is seeking information on innovative medical equipment, therapeutics, diagnostics and vaccines relative to COVID-19. The first step is to schedule a telephone call with the agency to discuss your innovative idea(s).

June 8, 2020

March 17, 2021

Basic Behavioral and Social Science Opportunity Network (NIH OPPNET)Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Well-Being, Illness and Recovery (R01)This Notice adds a deadline date and interests specific to COVID-19.
June 5, 2020Booz Allen FoundationInnovation FundThe goal of this new Fund is to help non-profits, entrepreneurs, thought leaders, innovators at colleges and universities and start-ups and small businesses harness the power of data, technology and diverse intellectual capital to improve COVID-19 relief efforts. Specifically, the Foundation is targeting solutions and projects that will build lasting community resilience through protecting vulnerable populations and frontline workers or providing  for the safe return to work.
Continuous submissionBrookhaven National Laboratory (US Department of Energy)COVID-19 Research SupportThe Center for Biomolecular Structure is supporting remote macromolecular crystallography experiments at the AMX and FMX beamlines and solution scattering experiments at the LiX beamline for COVID-19 research.
Applications accepted anytime through June 30, 2020 with reviews occurring every 2 weeksCoalition for Epidemic Preparedness Innovations (CEPI)Achieving an Unprecedented Acceleration of Vaccine Development and Global Manufacturing Capacity to Prevent COVID-19CEPI is supporting rapid vaccine development for consortium efforts around the world that are directed toward licensure/emergency authorization within 12-18 months. Manufacturers should either be consortium leads or consortium members.

CLINICAL TRIAL AWARD: Required Letters of Intent (LOIs) are due June 8, 2020; full proposals are then due June 22, 2020

 

INVESTIGATOR-INITIATED RESEARCH AWARD AND TECHNOLOGY/ THERAPEUTIC DEVELOPMENT AWARD: Required LOIs for both programs are due May 28, 2020 with full proposals then due June 12, 2020

Congressionally Directed Medical Research Program (DOD)Clinical Trial Award, Investigator-Initiated Research Award and Technology/ Therapeutic Development AwardThe sponsor has released an announcement to fund projects related to emerging viral diseases (i.e., COVID-19) and respiratory health. Biomedical and behavioral research efforts will be supported.
Applications accepted on rolling basisCOVID-19 Early Treatment Fund (CETF)Grants ProgramAdvocating early, effective treatment for COVID-19 patients designed to prevent hospitalization, CETF is supporting outpatient clinical trials of re-purposed antiviral drugs. 
July 17, 2020 for Phase 1 proposal submissions; finalists will move on to Phase 2, submitting revised proposals in September 2020data.org (New Venture Fund)Inclusive Growth and Recovery ChallengeThe sponsor has issued an open call for breakthrough ideas to use data science to help people and communities thrive - especially when dealing with COVID-19's economic effects. Three areas are being emphasized by the sponsor: Leave no worker behind, leave no entrepreneur behind and leave no place behind.
Continuous submissionDepartment of Energy
(US DOE)
Dear Colleague Letter - Corona Virus Disease 2019 (COVID-19)DOE is encouraging submission of scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.
Continuous submissionUS Department of Energy (DOE)Rapid Access for COVID-19 ResearchDOE is offering remote access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapeutics.
October 31, 2020
(this is final white paper submission deadline; full proposals will be invited by the sponsor)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)Broad Agency Announcement (BAA)BARDA is funding development of assays for coronaviruses.
June 30, 2020
(open for abstract submission through this date)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)

Division of Research Innovations and Ventures Easy Broad Agency Announcement (DRIVe)

 

While originally published with multiple topics, all have been closed and current work is now devoted to COVID-19. The sponsor is emphasizing the following topics: Remote Patient Monitoring and Diagnostic Tools, COVID-19  Vaccine, and Advanced Manufacturing Technologies (for vaccines and therapeutics). The sponsor has also closed a number of COVID-19 related topics as outlined in the latest Special Instructions 007.

Continuous SubmissionDiamond Light SourceRapid Access Call for Proposals: SARS-CoV-2Diamond, the UK's national synchotron, is offering its facilities and fragment screening expertise to researchers world-wide who are working on COVID-19 related projects.
June 30, 2020EASI-GenomicsExtraordinary Call for Proposals for Access Projects Related to the COVID-19 CrisisThis call focuses on making available whole-genome, whole exome and RNA sequencing of human patients from low-risk popoulations with severe forms of SARS-CoV-2 infection that have experienced adverse reactions or fatal outcomes. EASI-Genomics can also provide data analysis for already existing data sets.
June 5, 2020Emergency Medicine Foundation (EMF)COVID-19 Research GrantsEMF will support research to advance emergency patient care; improve response of hospitals, health care and EMS systems; and protect emergency medicine health care professionals during pandemics. Emergency medicine physicians must be the principal investigator or co-principal investigator on projects.
Fast Grant applications are currently paused due to receipt of a large number of qualified projects; if the sponsor can find additional funding, the program will resume.Emergent VenturesFast Funding for COVID-19 SciencePrincipal investigators at academic institutions who are currently working on a COVID-19 project that could help within the next 6 months and who require additional funding are eligible. First grant awards will be made on April 12, 2020; subsequent funding decisions will be made in under 48 hours. This grant program is administered by the Mercatus Center at George Mason University.
Continuous submissionExtreme Science and Engineering Discovery Environment (XSEDE)
(funded by the National Science Foundation)
COVID-19 HPC Consortium

This Consortium houses some of the most powerful and advanced computers in the world which will be made available to researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections.

None indicatedFacebookSymptom SurveysFacebook is offering access to survey data collected on a national and global level concerning Facebook users and COVID-19 symptoms. The Symptom Survey datasets are managed by Carnegie Mellon University and the University of Maryland. Academic and non-profit researchers may request access to the aggregated survey data. See the website for more details on survey methodology and the process for requesting data access.
Continuous submission until program funds are expended or the COVID-19 pandemic has endedFederal Communications Commission (FCC)COVID-19 Telehealth ProgramAvailable funding of $200 million for this program comes from the recently enacted CARES Act. It's designed to pay eligible health care providers (to include postsecondary educational institutions offering health care instruction, teaching hospitals and medical schools) to provide connected care services for patients by funding telecommunications services, information services and necessary devices. This is not a grant program; instead, after initial approval, provider expenses related to COVID-19 telehealth services for patients will be reimbursed (starting with expenses incurred after March 13, 2020).
Continuous application receipt through October 31, 2020Ferring PharmaceuticalsFerring COVID-19 Investigational Grants in Reproductive Medicine and Maternal HealthFerring will fund exploratory, basic and clinical research efforts about the effects of SARS-CoV-2 on reproduction, pregnancy and fetal/neonatal health. 
Submissions will be uploaded on the FIND website on a rolling basisFoundation for Innovative New Diagnostics (FIND)Open Call for Data - COVID-19

This Switzerland-based non-profit is asking laboratories around the world with any performance data on commercially available in vitro diagnostic tests that detect nucleic acid, viral antigen or antibodies to contribute to a centralized collection of data as a global public good. The data compilation will be made available on the FIND website to enable fast data sharing throughout the diagnostic community. 

No deadline indicatedGinkgo BioworksAccess to Platform for Partner COVID-19 ProjectsThe sponsor is offering access to its platform for company and academic labs engaged in developing a diagnostic, drug or vaccine to stop COVID-19.
Ongoing review

William T. Grant Foundation

Spencer Foundation

Rapid Response Research GrantsThe Grant Foundation will use the Rapid Response Research Grants mechanism to fund projects designed to combat youth inequality in the US, a main priority of the Foundation, made worse by the COVID-19 Pandemic. They are joined by the Spencer Foundation in this endeavor. These grants will fund collaborations between researchers and policymakers. Researchers on the team synthesize relevant literature within 6-8 weeks from the start of the grant award, and work with their policy partners to ensure the research results in actions benefiting youth.
Required letters of intent are due June 8, 2020; invited full applications are then due September 9, 2020.Health Effects Institute (HEI)Air Pollution, COVID-19 and Human Health (RFA 20-1B)HEI will consider applications that address: 1) Accountability Research - What are the effects of the unprecedented interventions taken to control the COVID-19 pandemic on emissions, air pollution and human health? and 2) Susceptability Factors - Are  individuals/populations who have been chronically or acutely exposed to higher levels of air pollution at greater risk of mortality from COVID-19 compared to those exposed to lower levels of air pollution? Do the effects differ by race/ethnicity or by measures of socioeconomic status?
July 7, 2020Intelligence Advanced Research Projects Agency (IARPA)COVID-19 Seedling Research Topics (IARPA-BAA-20-01)With this Broad Agency Announcement, IARPA is focusing interest on the need for technologies to assist with detection and sensing; supply chain management and integrity; geo-spatial-temporal monitoring and mapping with privacy protection; information reliability and collaboration tools; and modeling, simulation and predictive analytics.
Phase 1 Brief Proposals may be submitted anytime; full proposals will be invited by the sponsorRobert Wood Johnson Foundation (RWJF)Pioneering Ideas: Exploring the Future to Build a Culture of HealthRWJF is looking for future-focused projects in four focus areas to benefit their overall Foundation theme - Building a Culture of Health: 1) Future of Evidence, 2) Future of Social Interaction, 3) Future of Food and 4) Future of Work. Emphasis is on health equity. The sponsor notes that while this opportunity is focused on broader trends evolving prior to COVID-19, they are open to projects addressing the pandemic, either directly or indirectly.

Stage 1: June 3, 2020

Stage 2: 4 weeks after Stage 1

Joint European Disruptive Initiative (JEDI)Billion Molecules against COVID-19 Grand ChallengeThe goal of this Challenge is to screen billions of molecules with blocking interactions relevant to SARS-CoV-2 and fast-track the route to a therapeutic treatment. Research teams around the world are invited to respond.

June 18, 2020

 


The University is a member of MTEC. For assistance with this organization, please contact Dr. Jerome McKay in Emergency Medicine.

 

 


 

Medical Technology Enterprise Consortium (MTEC)Interoperable Medical Automated Systems (iMAS) Technology and Gap AssessmentThe purpose is to help develop a research prototype with the ability to tele-monitor and capture research data for the following research areas: COVID-19 wards, emergency rooms/trauma rooms and neurological patients.
None indicatedMercatus Center (at George Mason University)COVID-19 Response: A Call for IdeasThe sponsor is seeking proposals for policy briefs, working papers and articles addressing the next COVID-19 challenges facing the US and other countries: Reopening and restarting; institutional challenges, health and science policy; economic and regulatory policy; and monetary policy.
August 31, 2020Merck KgaAResearch Grant for Pandemic PreparednessProject proposals will be considered that leverage modern technologies to create new breakthrough solutions to (1) be more prepared for pandemic outbreaks or (2) work towards existing solutions that could help to fight emerging viral infections as part of the sponsor's overall 2020 Research Grants Program.
June 15, 2020 (or until further notice according to the sponsor)MicrosoftAI for Health COVID-19 GrantsMicrosoft is offering use of Azure cloud and High Performance Computing plus the opportunity to collaborate with their researchers.
June 18, 2020MIT SolveHealth Security and Pandemics ChallengeMIT Solve is seeking tech innovations that can slow and track the spread of an emerging outbreak, for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, and providing tools that support and protect health workers. Solve is also seeking solutions that focus on preventative and mitigation measures that strengthen access to affordable primary healthcare systems, enhance disease surveillance systems, and improve healthcare supply chains. All solutions selected for Solve’s five current Global Challenges will receive a $10,000 grant funded by Solve.
Applications accepted on rolling basisMozilla Open Source Support Program (MOSS)COVID-19 Solutions FundMOSS will fund open source technology projects related to COVID-19. Projects should be relatively well along as awardees are expected to use funds within 3 months of receipt.
Applications accepted through March 29, 2021National Aeronautics and Space Administration (NASA)Rapid Response and Novel Research in Earth Science ProposalNASA will provide new or additional support for studies using NASA satellite data to address regional-to-global environmental, economic and/or societal impacts of the COVID-19 pandemic. NASA is encouraging use of artificial intelligence/machine learning techniques.
Continuous submission (contact program officer first)National Cancer Institute (NCI)Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-1-Related Research during the CrisisNCI-funded researchers who wish  to be able to contribute their expertise and resources toward a better understanding of the impacts of SARS-CoV-2 infection and COVID-19 disease on cancer patients’ disease progression, response to therapy, care delivery, or survivorship may request variance to use a portion of their NCI project funds to address this crisis.

Applications accepted on a rolling basis from April 14, 2020 through June 25, 2020

 

 


 

CLARIFICATION AND DETAILS ABOUT THE DIFFERENT TYPES OF NIH SUPPLEMENTS AND HOW TO APPLY

 


 

National Cancer Institute (NCI)Notice of Special Interest: Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)Topics of interest include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer.
TBANational Cancer Institute (NCI)Serological Sciences Centers of Excellence (U54) and Research Projects (U01)NCI, through the Paycheck Protection Program and Health Care Enhancement Act, has been directed "to develop, validate, improve and implement serological testing and associated technologies." The goal is to characterize the immune responses elicited by SARS-CoV-2, especially as it relates to cancer patients. The agency intends to publish two Requests for Applications in June 2020, one to establish the Centers of Excellence and the other for research projects. Application due dates will likely be in July 2020.
Applications accepted on a rolling basis from May 15, 2020 through January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and then advance the translation of research findings into diagnostics, therapeutics, and vaccines.
Applications accepted on rolling basis from May 15, 2020 to January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in three specific topics: 1) Incorporation of new and emerging data related to SARS-CoV-2 into ongoing research efforts to develop microphysiological systems/tissue chips models for COVID-19; 2) Use of microphysiological systems/tissue chips or evaluating, repurposing or modification of diagnostic tools to enable rapid detection of COVID-19 infection; and 3) Use of microphysiological systems/tissue chips for the rapid development and assessment of potential therapeutic agents for COVID-19

U01 -
June 5, 2020
October 5, 2020

U34 -
June 16, 2020
October 16, 2020

UG3/UH3 -
June 26, 2020

National Center for Advancing Translational Sciences (NCAT/NIH)Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)This notice applies to three funding mechanisms offered by NCAT: Cooperative Agreement (U01), Planning Cooperative Agreement (U34) and Exploratory/Developmental Phased Award Cooperative Agreement (UG3/UH3)
Applications will be accepted on a rolling basis through August 17, 2020.

National Center for Complementary and Integrative Health (NCCIH)

Office of Research on Women's Health (ORWH)

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012)NCCIH is particularly interested in the therapeutic and/or mechanistic effects of natural product-based complementary remedies on SARS-CoV-2 (e.g., herbal therapies, vitamins, supplements, probiotics, microbial therapies, Chinese medicine herbal preparations).
Applications accepted on rolling basis through October 6, 2020

National Center for Complementary and Integrative Health (NCCIH)

 

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute of Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest: Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)Specific interest involves stress management strategies (including mind and body approaches) that individuals may engage in remotely to address stressors related to social distancing as well as to address recovery and reoccurrence of symptoms during or after COVID-19 infections.
Applications accepted on rolling basis through October 5, 2020National Heart, Lung and Blood Institute (NHLBI)

Notice of Special Interest: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019

 

Frequently Asked Questions Document (04/10/2020)

Of particular interest to NHLBI are studies that take advantage of human research or unique model systems to study the consequences of SARS-COV-2 infection.
Applications will be accepted on a rolling basis from May 1, 2020 through October 5, 2020.National Heart, Lung and Blood Institute (NHLBI)Notice of Special Interest: Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-2019) for Currently Active NHLBI Phase I-III Clinical TrialsTopics of special interest to NHLBI include safety and efficacy of interventions for primary prevention and/or treatment of COVID-19, associated clinical phenotypes, and surrogate outcomes relevant to heart, lung and blood diseases.
Applications accepted on rolling basis starting April 30, 2020National Institute of Allergy and Infectious Diseases (NIAID)

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Research Project Grants (R01)

Exploratory/Developmental Research Grants (R21)

NIAID is issuing these two program announcements to provide expedited funding mechanisms for research on SARS-CoV2 and COVID-19 to address the public health need for better understanding of virology, immunology, development of animal models and medical countermeasures (see announcements for full list). Another goal is to share findings quickly and broadly. Applications will receive expedited review and award.
This NOSI expires March 25, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

The funder is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics. Investigators seeking COVID-19 funding that falls within their current scope of work may instead request an administrative supplement (PA-18-591)

Deadlines vary by funding mechanism; this Notice expires September 8, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)Research areas are: Studies to understand critical aspects of viral infection, replication, pathogenesis and transmission; Studies on the evolution and emergence of SARS-CoV-2 viruses; Development of diagnostic tests; Development of SARS-CoV-2 therapeutic candidates; Identification and evaluation of the innate, cellular and humoral immune responses to SARS-CoV-2 infection; and Development of SARS-CoV-2 vaccine candidates. NIAID will be using the Small Grant (R03), SBIR and STTR funding mechanisms.
June 29, 2020National institute of Allergy and Infectious Diseases (NIAID)Partnerships for Countermeasures against Select Pathogens (R01)This funding announcement supports milestone-driven research projects focused on pre-clinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens (to include coronaviruses); requires evidence of substantial investment by at least one industrial partner.
Proposals may be submitted anytime until further notice; proposal review is promised within one weekNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Fast-Track Program for COVID-19 Test Development and Distribution - Rapid Acceleration of Diagnostics (RADx)The goal of this program is to enable rapid production of innovative SARS-CoV-2 diagnostic tests. Both early and advanced stage projects will be supported.
First available application deadlines are June 5 and June 16, 2020 - depending on funding mechanism; this NOSI expires March 31, 2021National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)The sponsor will fund applications to develop life-saving technologies for commercialization within one to two years.
Applications accepted on rolling basis through November 10, 2020National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years.
Applications accepted on rolling basis through April 15, 2021National Institute on Alcohol Abuse and Alcoholism (NIAAA)Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAANIAAA is requesting applications to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes.

November 2, 2020

National Institute of Dental and Craniofacial Research (NIDCR)Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCRNIDCR will place high priority on topics of immediate and high impact to protect and ensure safety of personnel and patients in dental practices. These topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Topics addressing influence and interaction of sex (a biological variable) and gender (a social construct), race and ethnicity, and those addressing questions about risk, prevention, and health outcomes are also of interest.
Applications for both types are due July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; and May 3, 2021. This NOSI will expire on May 4, 2021.National Institute of Environmental Health Sciences (NIEHS)Notice of Special Interest: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)NIEHS will support both time-sensitive new projects and emergency competitive revisions from current grantees to study the role of environmental exposures in pathogenicity, transmission, individual susceptability, or prevention and intervention strategies.
Applications will be accepted on a rolling basis through April 15, 2021.

National Institute of Mental Health (NIMH)

 

Other Participating Institutes:

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute on Minority Health and Health Disparities

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusNIMH is especially interested in research to (1) provide an evidence base for how a disrupted workforce may respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, (2) learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health and (3) address the intersection of COVID-19, mental health, and HIV treatment and prevention.
Applications accepted through April 14, 2021

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemNINDS will support supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae or treatment of the Novel Coronavirus 2019; NIAAA is interested in studies to better understand, prevent and mitigate some of the neurobiological consequences of SARS-CoV-2 and COVID-19 in individuals with Alcohol Use Disorders.
Applications accepted on a rolling basis from April 6, 2020 through May 1, 2021

National Institute on Aging (NIA)

 

Other Participating Institutes:

National Institute of Mental Health (NIMH)

Notice of Special Interest: NIH Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019

 

FAQ Document

This NOSI is designed to address the urgent public health need to better understand the 2019-nCoV, particularly to improve prevention of disease transmission among older adults and mitigation of disease severity/mortality in older adults with COVID-19.
Standard NIH deadlines apply; the first deadline will be October 5, 2020

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute on Drug Abuse (NIDA)

National Cancer Institute (NCI)

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 - Clinical Trial Optional)Will support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters (to include COVID-19) on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.
Applications accepted on rolling basis from May 1, 2020 through May 1, 2021

National Institute on Minority Health and Health Disparities (NIMHD)

 

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute of Mental Health (NIMH)

Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesNIMHD is soliciting research in health disparity populations to better understand: 1) how state and local policies and initiatives mitigate/exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations.

September 4, 2020

(Note institutions are limited to 2 applications for this competition; our internal selection process will run through the Office of the Vice Chancellor for Research.)

National Institutes of HealthFY 2021 NIH Director's Early Independence Award (DP5): COVID-19 Proposals (RFA-RM-20-021)This award supports outstanding junior scientists, defined as those currently in non-independent positions at time of application who have not served in a postdoctoral position more than 12  months. Preliminary data are not required. 
September 30, 2020National Institutes of HealthFY 2021 NIH Director's Emergency Transformative Research Award (R01): COVID-19 Proposals (RFA-RM-20-020)The purpose of this award is to provide support for individuals and teams at all career levels who are proposing COVID-19 related projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. Proposals may address COVID-19 prevention, preparation or response. No preliminary data are required.
June 16, 2020National Library of Medicine (NLM)Notice of Special Interest: Data Driven Research on Coronavirus 2019 (COVID-2019)The focus is on informatics and data science methods to help address the COVID-19 pandemic. Specific research areas are methods for mining clinical data and public health surveillance methods.
No set deadlineNational Science Foundation (NSF)Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)

NSF encourages investigators to use the Rapid Response Research (RAPID) funding mechanism to address COVID-19 which allows for quick turnaround time to meet project requirements. The first step is to contact the program officer as RAPID proposals require program officer permission to submit.

NSF is also encouraging investigators to submit to existing funding opportunities such as the Ecology and Evolution of Infectious Diseases program, jointly funded by NSF, NIH, USDA and others; proposals are due November 18, 2020.

Medium Proposals are due 06/22/20

Frontier Proposals are due 12/02/20

National Science Foundation/National Institutes of Health (and a host of other federal agencies)Cyber-Physical Systems (CPS)Core research areas of this initiative are control, data analytics and machine learning. NIH mentions supporting "development of CPS research and technology to facilitate medical treatment during a national crisis (e.g., SARS-CoV-2)" (see Section II.D.3 of the program solicitation for details).
No set deadlineNational Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-2019)

NSF is inviting RAPID proposals and supplemental funding requests to existing awards to address COVID-19 challenges through data and/or software infrastructure development activities. Again, program officer permission is required prior to proposal submission.

Applications accepted on a rolling basis through March 31, 2021

Office of Behavioral and Social Sciences Research (OBSSR)

 

Other Participating Institutes:

National Heart, Lung and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesOBSSR is encouraging urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.
Applications will be accepted on a rolling basis through June 19, 2020.Office of Strategic Coordination (OSC) - [NIH Common Fund]Notice of Special Interest: Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)Designed to rapidly improve understanding, diagnosis and treatment of COVID-19, OSC is encouraging current Common Fund grantees to submit technologically or conceptually innovative applications.
Proposals considered on a rolling basisPatient-Centered Outcomes Research Institute (PCORI)COVID-19-Related Enhancements to Existing PCORI-Funded Engagement AwardsOnly PCORI-funded project leads with active Engagement Awards are eligible for this competition. Enhancements may include modest additions to existing aims or an adjunct project that has some relationship to the original award.
Proposals considered on a rolling basisPatient-Centered Outcomes Research Institute (PCORI)COVID-19-Related Enhancements to Existing PCORI-Funded Research ProjectsOnly PCORI-funded principal investigators with active research funding contracts are eligible for this competition. Enhancements may include modest additions to existing aims or an adjunct project that has some relationship to the original award.
June 17, 2020Pfizer, Inc.Vaccine Preventable Diseases - COVID-19Pfizer will support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures.

June 1, 2020 - Letters of intent due

July 1, 2020 - Applications due

Rheumatology Research FoundationNotice of Special Interest: Relationships between Rheumatic and Musculoskeletal Diseases and SARS-CoV-2The Foundation will support basic, clinical, translational, health services and patient- or practice-centered research efforts related to SARS-CoV-2.
Proposals accepted on rolling basis until June 8, 2020; the Foundation will be reviewing proposals received during 3 review cycles; cutoff dates are May 4, 2020, May 18, 2020 and June 8, 2020Spencer FoundationCOVID-19 Related Special Grant CycleSpencer is interested in funding educational research projects to aid understanding of rapid shifts in education that have occurred due to the COVID-19 crisis. They will support 2 grant categories: 1) Projects designed to understand and disrupt the reproduction and deepening of educational inequality caused by the COVID-19 crisis, and 2) Projects to remake and imagine new forms of equitable education in this time frame. Proposals at all educational levels and learning settings are encouraged (e.g., early childhood, higher ed, families, communities). The Foundation is also interested in studies related to English language learners, immigrants, minoritized communities, indigenous communities, students with disabilities, and rural communities.
Applications will be reviewed on rolling basis through June 12, 2020Stevens Initiative

Coronavirus Response Fund

 

(Background information on the Stevens Initiative)

This organization, set up to honor the life of Ambassador Chris Stevens, will support educational outreach among organizations in the US, the Middle East and North Africa, calling them "virtual exchange programs". Priority areas are technology and computing, world affairs and global studies, business and entrepreneurship, language learning and practice, and public health and/or the coronavirus pandemic.
July 13, 2020US Department of Agriculture (USDA)Distance Learning and TelemedicineUSDA added a deadline for this program, and is encouraging distance learning/telemedicine outreach to rural areas relevant to COVID-19.
June 4, 2020US Department of Agriculture National Institute of Food and Agriculture (NIFA)Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural SystemsThrough this new program priority, NIFA will address the need to develop and deploy rapid, reliable, and readily adoptable strategies across the food and agriculture enterprise in response to the COVID-19 pandemic. Topics of interest include health and security of livestock; food and food processing; well-being of farm, food service providers and rural Americans; and economic security.